PUGLIESE, NOVELLA
 Distribuzione geografica
Continente #
AS - Asia 2.009
EU - Europa 1.595
NA - Nord America 1.365
SA - Sud America 299
AF - Africa 70
OC - Oceania 8
Totale 5.346
Nazione #
US - Stati Uniti d'America 1.298
SG - Singapore 1.012
RU - Federazione Russa 818
CN - Cina 517
IT - Italia 353
BR - Brasile 239
HK - Hong Kong 176
VN - Vietnam 149
DE - Germania 109
NL - Olanda 64
GB - Regno Unito 50
FR - Francia 47
FI - Finlandia 41
IN - India 38
CI - Costa d'Avorio 34
KR - Corea 31
CA - Canada 28
MX - Messico 27
IE - Irlanda 22
SE - Svezia 22
AR - Argentina 21
PL - Polonia 17
ZA - Sudafrica 15
AT - Austria 13
EC - Ecuador 13
BD - Bangladesh 12
TR - Turchia 12
UA - Ucraina 11
IQ - Iraq 9
ID - Indonesia 8
CO - Colombia 7
CZ - Repubblica Ceca 7
UZ - Uzbekistan 7
JP - Giappone 6
MA - Marocco 6
NP - Nepal 6
ES - Italia 5
LT - Lituania 5
PE - Perù 5
PK - Pakistan 5
AU - Australia 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BE - Belgio 3
CL - Cile 3
DO - Repubblica Dominicana 3
IL - Israele 3
PA - Panama 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
VE - Venezuela 3
BO - Bolivia 2
EG - Egitto 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
NC - Nuova Caledonia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CU - Cuba 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
IS - Islanda 1
KZ - Kazakistan 1
MK - Macedonia 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
UG - Uganda 1
YE - Yemen 1
Totale 5.346
Città #
Singapore 497
Moscow 209
Chandler 193
Hong Kong 176
Beijing 155
Hefei 147
Ashburn 143
Naples 86
Santa Clara 77
Amsterdam 56
Los Angeles 50
Munich 50
Dong Ket 46
Ho Chi Minh City 40
Dallas 39
Millbury 34
Napoli 30
Seoul 30
Seattle 25
Des Moines 24
Buffalo 23
São Paulo 23
Hanoi 22
Boston 20
Lawrence 19
New York 19
Denver 17
London 15
Poplar 15
Princeton 14
Turku 14
Helsinki 13
Mexico City 13
Nanjing 13
Frankfurt am Main 11
Kochi 11
Phoenix 11
Redondo Beach 11
Warsaw 11
Milan 10
Wilmington 10
Atlanta 9
Orem 9
Rio de Janeiro 9
The Dalles 9
Chicago 8
Nocera Inferiore 8
Nuremberg 8
Tianjin 8
Guayaquil 7
Ottawa 7
Stockholm 7
Toronto 7
Ankara 6
Brooklyn 6
Chennai 6
Dublin 6
Düsseldorf 6
Houston 6
Lauterbourg 6
Montreal 6
Nanchang 6
Norwalk 6
Rome 6
Rose 6
Roubaix 6
San Francisco 6
Shanghai 6
Campinas 5
Falkenstein 5
Haiphong 5
Lappeenranta 5
Mondragone 5
Porto Alegre 5
Pune 5
Salvador 5
Tashkent 5
Tokyo 5
Turin 5
Afragola 4
Belo Horizonte 4
Bengaluru 4
Brasília 4
Caserta 4
Changsha 4
Gesualdo 4
Luzzano 4
Manchester 4
Paris 4
Shijiazhuang 4
Vienna 4
Baghdad 3
Bitonto 3
Brussels 3
Buenos Aires 3
Bắc Ninh 3
Calgary 3
Casal di Principe 3
Charlotte 3
Columbus 3
Totale 2.738
Nome #
2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma 156
(1-3)-β-d-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations 152
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison 146
Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma 144
Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL 140
Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21 129
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience 127
Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma 127
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 125
Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Study 124
Secondary syphilis mimicking malignancy: A case report and review of literature 124
Advanced-stage Hodgkin Lymphoma: US/Chest Radiography for Detection of Relapse in Patients in First Complete Remission—A Randomized Trial of Routine Surveillance Imaging Procedures 123
Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1,3-β-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography 123
Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma 121
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 120
MOLECULAR EVALUATION OF ZNF224 MRNA EXPRESSION IN CML PATIENTS AS A NOVEL DETERMINANT OF TKI RESPONSIVENESS 119
A Novel Score to Predict Interferon-Alpha Therapy Responsiveness in Patients with Essential Thrombocythemia 116
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma 114
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis 112
Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support 111
Rituximab-containing risk-adapted treatment strategy in nodular lymphocyte predominant hodgkin lymphoma: 7-years follow-up 109
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 107
Correspondence in reference to the previously published Epub manuscript by Peter Hokland et al. 'How I treat advanced Hodgkin lymphoma - a global view'. Br J Haematol. 2020;190:837-50 107
Ultrasonography-guided core-needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front-line biopsies in a multicenter Italian study 105
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial 103
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib 100
Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease 100
Involvement of Helicobacter Pylori in Ocular Adnexa Lymphoma 100
Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury 99
Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia 97
Feasibility of semi-recumbent bicycle exercise Doppler echocardiography for the evaluation of the right heart and pulmonary circulation unit in different clinical conditions: the RIGHT heart international NETwork (RIGHT-NET) 96
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study 93
Cyclic Neutropenia Mimicking Crohn's Disease: Two Case Reports and a Narrative Review 93
Correspondence in reference to the previously published Epub manuscript: “Murt Ahmet et al. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 2020; 99: 2671-2677” 93
Sulfur Exafluoride Contrast-Enhanced Ultrasound Showing Early Wash-Out of Marked Degree Identifies Lymphoma Invasion of Spleen with Excellent Diagnostic Accuracy: A Monocentric Study of 260 Splenic Nodules 93
Correspondence in reference to previously published manuscript: "Faouzi Djebbari et al. Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphoma. Eur J Haematol 2020; 105: 667-671." 90
Long-term Cryopreserved Autologous Hematopoietic Stem Cells Following Azacytidine to Successfully Treat Severe Invasive Pulmonary Aspergillosis After Therapy-Related Myelodysplastic Syndrome and CD8+ T-cell Autoimmune Disorders: A Case Report 89
Regarding "Hepatitis B surface antigen positivity is an independent unfavorable prognostic factor in diffuse large B-cell lymphoma in the rituximab era" 87
Reply to the letter to the editor "chronic disseminated candidiasis" by Kenneth Rolston 86
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis 85
Randomized Comparison of Power Doppler Ultrasonography-Guided Core-Needle Biopsy with Open Surgical Biopsy for the Characterization of Lymphadenopathies in Patients with Suspected Lymphoma, 83
Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma 79
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 79
Consolidation radiotherapy following positron emission tomography complete response in early-stage Hodgkin lymphoma: a meta-analysis 79
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome 77
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy 73
Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study 73
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study 64
Ultrasonography-guided core-needle biopsy for newly diagnosed large b-cell lymphomas: Analysis on Diagnostic efficacy and safety in a Italian retrospective study. 62
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis 62
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia 61
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome 56
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis 56
Second primary malignancy in myelofibrosis patients treated with ruxolitinib 44
Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers 22
Spleen volume assessment in Ph-negative chronic myeloproliferative neoplasms: a real-life study comparing ultrasonography vs. magnetic resonance imaging scans 15
Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin–bleomycin–vinblastine–dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study 15
Routine imaging surveillance after frontline ABVD improves outcome in high-risk hodgkinn lymphoma 13
Totale 5.498
Categoria #
all - tutte 17.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 13 1 12 17 5 3 48
2021/2022278 4 3 11 1 5 14 9 5 21 20 111 74
2022/2023458 34 40 23 18 68 45 7 53 78 63 17 12
2023/2024265 11 32 26 21 13 26 5 59 4 8 34 26
2024/20251.794 56 25 6 22 47 120 173 133 109 239 706 158
2025/20262.293 368 315 453 358 688 111 0 0 0 0 0 0
Totale 5.498